BiotechTube
Home/MiNK Therapeutics/Jenny Gumperz, Ph.D.
JG

Jenny Gumperz, Ph.D.

Scientific Advisor

MiNK Therapeutics

Therapeutic Areas

OncologyImmunologyPulmonary Diseases

MiNK Therapeutics Pipeline

DrugIndicationPhase
MiNK-101Relapsed/Refractory Solid TumorsPhase 1
MiNK-201Acute Respiratory Distress Syndrome (ARDS)Phase 1b/2
CAR-iNKT ProgramsHematological and Solid TumorsPreclinical

Leadership Team at MiNK Therapeutics

JB
Jennifer Buell, Ph.D.
President and Chief Executive Officer
GA
Garo Armen, Ph.D.
Chairman of the Board
MV
Marc van Dijk, Ph.D.
Scientific Advisor (Former CSO)
RS
Robert Stein, M.D., Ph.D.
Scientific Advisor
MH
Manuel Hidalgo, M.D., Ph.D.
Scientific Advisor
ME
Mark Exley, Ph.D.
Scientific Advisor
LL
Lydia Lynch, Ph.D.
Scientific Advisor
MM
Marcela Maus, M.D., Ph.D.
Scientific Advisor
PB
Peter Behner
Director
BC
Brian Corvese
Director
View full MiNK Therapeutics profile